# Clara Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clara-health

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.askclara.com/
- Latest round: Seed (Jun 24, 2026)
- Investors on record: 1

## About

Based in San Francisco, US, founded in 2025, Clara Health, Inc., operates an AI-powered platform that aggregates health data to help individuals manage their health. The company was co-founded by George Favvas (CEO as of 2026), Caitlin Swift and Zeeshan Ahmed. In May 2026, Clara Health, Inc., raised USD 12 million in pre-seed funding co-lead by Y Combinator and A.Capital, with participation from Liquid 2 Ventures and SV Angel.
Clara Health, Inc., offers an AI-powered primary care service designed to enhance patient health management through continuous, accessible care. The core product is an AI-driven platform that consolidates health data from various sources, including personal medical histories, lab results, and wearable device metrics, to create personalized care plans. The service is staffed by board-certified clinicians who review all medical recommendations, ensuring human oversight in clinical decisions. Clara Health, Inc., targets individuals seeking a comprehensive and responsive approach to their healthcare, particularly those with chronic conditions or those pursuing preventative care. The company serves clients primarily in the United States, catering to a diverse user base that includes patients with conditions such as diabetes, thyroid issues, and fatigue.
Clara Health, Inc., generates revenue through a subscription-based model, wherein customers pay for access to its AI-powered healthcare services. The subscription provides users with a suite of offerings, including prescription management, lab order facilitation, and personalized health insights, all reviewed by licensed clinicians. While specific pricing plans are tailored to individual needs, they typically include options for both monthly and annual subscriptions. Clara Health, Inc., business model emphasizes direct-to-consumer transactions, facilitating a seamless experience for users who benefit from an integrated health service without the traditional constraints of in-person visits. This approach allows for continuous engagement with clients, as the platform adapts care plans in real-time, reflecting users' evolving health profiles.
The company plans to use the May 2026 funding for future growth and expansion.

## Funding rounds

- Seed, Jun 24, 2026 — Pioneer Fund

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed